with Steven Huang
In this episode, Cameron sits down with Steven Huang, the Director of Finance, People, IT, and Community at MAPS, the Multidisciplinary Association for Psychedelic Studies. Steven helps lead global efforts to bring psychedelic research, policy reform,…

In this episode, Cameron sits down with Steven Huang, the Director of Finance, People, IT, and Community at MAPS, the Multidisciplinary Association for Psychedelic Studies. Steven helps lead global efforts to bring psychedelic research, policy reform, and public understanding into the mainstream, building on MAPS’ 40-year history at the forefront of mental health innovation.
Steven shares his unlikely path from life insurance actuary to Silicon Valley analyst to psychedelic industry operator, including how psychedelics shaped his career decisions, his leadership growth, and his move into the second-in-command role during a major organizational crisis. He and Cameron explore what the government is getting right, where the psychedelic movement is headed, and how MAPS balances scientific rigor with visionary cultural work.
If you’ve been watching psychedelics move from taboo to the TED stage to boardrooms and leadership circles, this conversation gives a rare inside look at the movement from someone steering the ship.
Steven Huang is the Director of Finance, People, IT, and Community at MAPS, the Multidisciplinary Association for Psychedelic Studies. With a background spanning actuarial science, Facebook’s people analytics team, and diversity leadership roles across Silicon Valley, Steven brings a rare mix of analytical rigor and human-centered leadership to one of the most complex and culturally significant organizations in mental health and policy reform. His work today sits at the intersection of science, policy, and healing, helping MAPS navigate growth, government regulation, organizational change, and the future of psychedelic-assisted therapy.
Resources & Mentions
- MDMA-assisted therapy
- Ketamine therapy
- Psilocybin
- Ayahuasca
- Psychedelic Science Conference
- Resilient Pharmaceuticals (formerly Lykos Therapeutics)
- Rick Doblin
Important Links
- Connect with Cameron: Website | LinkedIn
- Explore the COO Alliance® - The World’s Leading Community for Seconds in Command
- Get Cameron’s book: Second in Command: Unleash the Power of Your COO Book
- Take his course: Invest In Your Leaders Online Course (Use promo code PODCAST10 before the end of the month for 10% off)
- Chat or video call with AI Cameron via Delphi

Known as “The CEO Whisperer,” Cameron grew 1-800-GOT-JUNK? from $2M to $106M in six years and is the bestselling author of The Second in Command, Vivid Vision and Meetings Suck. In 2016 he founded COO Alliance, the world’s leading community for Second in Command leaders.
The world’s best Second in Command leaders are already inside. Join operational leaders who’ve been where you are, and have the frameworks to get you there faster.
Membership is reviewed and selective. $2M+ company revenue required.


